Scientists at City of Hope and TGen (part of City of Hope) are the first to explain a major mechanism for why gaining excess ...
While participants on a lower dose of Wave Life Sciences’ RNA therapy lost 5.3% total fat at the six-month mark, those ...
10don MSN
Eli Lilly’s next-generation obesity drug retatrutide clears first late-stage diabetes trial
Lilly is betting big on retatrutide as the next pillar of its obesity portfolio after its weight loss injection Zepbound and ...
Zacks Investment Research on MSN
VKTX finishes enrollment in second late-stage study on obesity drug
Shares of Viking Therapeutics VKTX rose more than 3% on Thursday after the company announced that it completed enrollment in ...
By Kamal Choudhury March 26 (Reuters) - Wave Life Sciences shares plunged 58% on Thursday after a higher dose of its experimental obesity drug failed to show a clear improvement at reducing a ...
The drugmaker said UBT251 achieved mean body weight reduction of up to 9.8% after a 24-week trial.
A new study analyzing data from the Centers for Disease Control and Prevention has found that Indiana ranks among the states with the highest adult obesity rates in the United States.
For parents of a child with obesity, a normal lab report from the pediatrician may suggest that their weight isn’t yet a ...
2don MSN
BMI classification system wrongly identifies some people as having overweight or obesity, says study
Research from Italy to be presented at this year's European Congress on Obesity (ECO 2026, Istanbul, Türkiye, 12–15 May) and published in the journal Nutrients shows that when the gold standard ...
On March 26, 2026, traders mulled Wave's weak high-dose obesity results against the company's large market opportunity.
Novo Nordisk A/S is doubling down on obesity and diabetes, putting it at loggerheads with investors calling for the Danish ...
The Obesity Charter for Cambridgeshire and Peterborough set out a vision in which "healthy weight is the norm" within 20 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results